Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

InfoBionic.Ai Advances Cardiac Monitoring to Assist Physicians in Women's Heart Care


News provided by

InfoBionic.Ai

Feb 25, 2025, 10:04 ET

Share this article

Share toX

Share this article

Share toX

IFB PRS 01
IFB PRS 01

Women's cardiovascular health is shaped by unique risks, from hormonal changes to the impact of cancer treatments. Proactive monitoring and personalized care are essential. InfoBionic.Ai's MoMe ARC® delivers real-time cardiac insights, empowering physicians to improve patient outcomes.

BOSTON, Feb. 25, 2025 /PRNewswire-PRWeb/ -- A recent study published in the Journal of the American Medical Association (JAMA) suggests a link between cardiovascular disease (CVD) and breast cancer. The case-control study found that women with cardiovascular disease were more likely to be diagnosed with advanced-stage breast cancer, specifically hormone receptor-positive, ERBB2-negative (formerly HER2-negative) subtypes. (1) "While these findings are still in their early stages, the emerging connection between cardiovascular disease and breast cancer underscores the critical need for early detection and continuous heart health monitoring—especially during pivotal hormonal transitions such as menopause," explains Anna Norman, Vice President of Product for InfoBionic.Ai. "Although researchers are still investigating the exact mechanisms behind this link, the evidence reinforces the necessity of a more integrated approach to women's healthcare."

Gender Differences in Heart Disease Symptoms and Treatment
Despite heart disease being the leading cause of death among both men and women, there are stark differences in how it presents and is treated. Women often experience atypical heart attack symptoms, such as nausea, fatigue, and jaw pain, leading to delays in diagnosis and treatment. Studies indicate that biological factors, including sex hormones, contribute to differences in cardiovascular disease prevalence and severity between men and women. (2)
Additionally, research suggests that heart attack diagnoses are missed more frequently in women than in men. (3) These disparities reinforce the need for gender-specific approaches to cardiovascular care and patient education.

"The ability to continuously monitor cardiovascular health is a game-changer in proactive women's healthcare" — Anna Norman, Vice President of Product for InfoBionic.Ai

Post this

The Role of Hormones in Women's Cardiovascular Health
Hormonal fluctuations, particularly the decline in estrogen levels during menopause, play a critical role in cardiovascular health. Estrogen provides a protective effect on blood vessels, and its loss increases the risk of hypertension, atherosclerosis, and other cardiovascular conditions. Research from the Mayo Clinic explains how declining estrogen levels contribute to arterial plaque buildup, raising the likelihood of heart attacks and strokes in postmenopausal women. (4) Additionally, findings from the Swedish Nationwide Register suggest that outcomes of hormone replacement therapy (HRT) vary depending on the timing and type of therapy used. (5)
A study using NHANES data from 1999–2020 further reinforces the connection, showing a significant association between female hormone intake and cardiovascular disease risk. (6) These findings stress the need for personalized medical interventions to mitigate cardiovascular risks in women undergoing hormonal changes.

Breast Cancer Treatment and Long-Term Cardiovascular Risk
While the connection between pre-existing CVD and advanced breast cancer is gaining attention, research also highlights the long-term cardiovascular risks faced by breast cancer survivors. A study published in The Journal of Clinical Oncology found that breast cancer patients treated with anthracyclines and trastuzumab—a common chemotherapy regimen—had an increased risk of heart failure and other cardiovascular complications. (7)
Furthermore, The Impact of Cardiovascular Disease on All-Cause and Cancer Mortality, a 16-year follow-up study from Germany, found that breast cancer patients with CVD had significantly higher mortality rates, reinforcing the need for integrated cancer and cardiovascular care. (8)

The Path Forward: Integrating Women's Heart and Cancer Care
As research continues to reveal the intricate connections between various health conditions, it is imperative that healthcare providers adopt a more integrated approach to women's health. This includes:

  • Proactive cardiovascular screening for women, particularly those undergoing breast cancer treatment or experiencing menopause.
  • Personalized hormone therapy strategies that consider cardiovascular risks and benefits.
  • Education on heart attack symptoms in women to promote early detection and intervention.
  • Advanced cardiac monitoring technologies to provide continuous insights into heart health.

Advancing Women's Cardiovascular Care with Continuous Monitoring
As awareness grows around women's unique cardiovascular risks, the healthcare industry is developing more advanced monitoring tools to improve patient care. Continuous cardiac monitoring can play a pivotal role in identifying irregular heart activity, allowing for early intervention and better patient outcomes.
InfoBionic.Ai's MoMe ARC® platform is a remote cardiac monitoring solution designed to support physicians in evaluating heart health by providing continuous ECG data. Once prescribed by a doctor, MoMe ARC® helps identify cardiac abnormalities in patients already experiencing symptoms, offering clinicians valuable insights into cardiovascular conditions. While the platform does not play a role in early detection, it enhances patient care by enabling real-time monitoring, which is particularly relevant for women managing cardiovascular risks associated with hormonal changes or a history of breast cancer.
"The ability to continuously monitor cardiovascular health is a game-changer in proactive women's healthcare," Norman emphasis. "While no single solution can eliminate risk, combining advanced monitoring technology with comprehensive medical care enables clinicians to make timely and informed decisions that can ultimately save lives."

About InfoBionic.Ai
InfoBionic.Ai's digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company's vision for its FDA-cleared third-generation platform, the MoMe ARC®, is to remove the roadblocks hindering virtual and remote diagnosis and decision-making. The Massachusetts-based team of seasoned entrepreneurs has had successful careers in healthcare, IT, medical devices, and mobile technology, and brings specific expertise in remote monitoring and cardiology. Visit https://infobionic.ai

References
1.    Angelov, Ivan, et al. "Cardiovascular Disease and Breast Cancer Stage at Diagnosis." JAMA, 2 Jan. 2025, jamanetwork.com/journals/jamanetworkopen/fullarticle/2828637.
2.    Regitz-Zagrosek, Vera, and Catherine Gebhard. "Gender Medicine: Effects of Sex and Gender on Cardiovascular Disease Manifestation and Outcomes." Nature Reviews Cardiology, vol. 20, 31 Oct. 2022,doi.org/10.1038/s41569-022-00797-4.
3.    Antipolis, Sophia. "Heart Attack Diagnosis Missed in Women More Often than in Men." escardio.org, 12 Mar. 2021, escardio.org/The-ESC/Press-Office/Press-releases/Heart-attack-diagnosis-missed-in-women-more-often-than-in-men
4.    Williams, Vivien. "Mayo Clinic Minute: Women, Estrogen and Heart Disease." Mayo Clinic, Mayo Foundation for Medical Education and Research, 18 Mar. 2022, newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-women-estrogen-and-heart-disease/#:~:text=Men%20and%20women%20have%20an,of%20estrogen%20as%20the%20cause
5.    Johansson, Therese, et al. "Contemporary Menopausal Hormone Therapy and Risk of Cardiovascular Disease: Swedish Nationwide Register Based Emulated Target Trial." The BMJ, British Medical Journal Publishing Group, 27 Nov. 2024, bmj.com/content/387/bmj-2023-078784
6.    Qu, Shenao, et al. "Association between the Female Hormone Intake and Cardiovascular Disease in the Women: A Study Based on Nhanes 1999–2020 - BMC Public Health." BioMed Central, BioMed Central, 24 Dec. 2024, bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21001-x
7.    Greenlee, Heather, et al. "Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study." Journal of Clinical Oncology, ASCO, 6 Apr. 2022, ascopubs.org/doi/10.1200/JCO.21.01736.
8.    Möhl, Annika, et al. "The Impact of Cardiovascular Disease on All-Cause and Cancer Mortality: Results from a 16-Year Follow-up of a German Breast Cancer Case–Control Study - Breast Cancer Research." BioMed Central, BioMed Central, 27 July 2023, breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-023-01680-x

Media Inquiries:
Karla Jo Helms
JOTO PR™
727-777-4629
jotopr.com

Media Contact

Karla Jo Helms, JOTO PR™, 727-777-4629, [email protected], jotopr.com

SOURCE InfoBionic.Ai

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.